|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/395 |
| (11) | Number of the document | 1907000 |
| (13) | Kind of document | T |
| (96) | European patent application number | 06784684.0 |
| Date of filing the European patent application | 2006-06-08 | |
| (97) | Date of publication of the European application | 2008-04-09 |
| (45) | Date of publication and mention of the grant of the patent | 2012-10-17 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2006/022423 |
| Date | 2006-06-08 |
| (87) | Number | WO 2006/133396 |
| Date | 2006-12-14 |
| (30) | Number | Date | Country code |
| 688872 P | 2005-06-08 | US |
| (72) |
FREEMAN, Gordan, US
SHARPE, Arlene, US
DORFMAN, David, M., US
AHMED, Rafi, US
BARBER, Daniel, US
WHERRY, E., John, US
|
| (73) |
The President and Fellows of Harvard College,
17 Quincy Street, Cambridge, MA 02138,
US
DANA-FARBER CANCER INSTITUTE, 44 Binney Street, Boston, MA 02115, US The Brigham and Women`s Hospital, Inc., 75 Francis Street, Boston, MA 02215, US Emory University, 1599 Clifton Road NE 4th Floor, Atlanta, GA 30322, US |
| (54) | Methods and compositions for the treatment of persistent HIV infections by inhibiting the programmed cell death 1 (PD-1) pathway |
| Methods and compositions for the treatment of persistent HIV infections by inhibiting the programmed cell death 1 (PD-1) pathway |